← Browse by Condition
Medical Condition
pain postoperative
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 4
Pain clinical trials span acute procedural pain, chronic musculoskeletal pain, neuropathic pain, and cancer-related pain — each requiring distinct trial designs and patient-reported outcome instruments. The regulatory demand for non-opioid alternatives has intensified the search for novel analgesic mechanisms, particularly ion channel targets and neurostimulation approaches.
Active trials evaluate Nav1.7/1.8 blockers, CGRP antagonists for new indications, spinal cord stimulation refinements, virtual reality-based pain management, and patient-specific ketamine infusion protocols. Pain trials increasingly use ecological momentary assessment (EMA) diary approaches over traditional recall-based pain rating scales.
Frequently Asked Questions — pain postoperative Clinical Trials
How many clinical trials are currently recruiting for pain postoperative?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for pain postoperative, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pain postoperative?
pain postoperative research spans Phase 1 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pain postoperative clinical trial?
Eligibility criteria for pain postoperative trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 4 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06498713 Phase 1
Recruiting
Patient Controlled Administration of Liquid Acetaminophen
Enrollment
24 pts
Location
United States
Sponsor
Yale University
NCT07550348
Recruiting
Bupivacaine-Lidocaine vs Bupivacaine for Ultrasound-Guided Popliteal Sciatic Nerve Block
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Ataturk University
NCT04860141 Phase 4
Recruiting
Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.
Enrollment
98 pts
Location
United States
Sponsor
Loma Linda University
NCT06420388
Recruiting
2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy
Enrollment
400 pts
Location
Taiwan
Sponsor
E-DA Hospital
NCT06094257
Recruiting
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
Enrollment
400 pts
Location
United States
Sponsor
Weill Medical College of Corne...
NCT03737604 Phase 4
Recruiting
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
Enrollment
200 pts
Location
United States
Sponsor
University of California, Davi...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology